Summary
Charcot-Marie-Tooth disease (CMT) is a clinically and genetically heterogeneous condition characterized by peripheral axon degeneration with subsequent motor and sensory deficits. Several CMT gene products function in endosomal sorting and trafficking to the lysosome, suggesting that defects in this cellular pathway may present a common pathogenic mechanism for these conditions. LRSAM1 is an E3 ubiquitin ligase that is implicated in this process, and mutations in LRSAM1 have recently been shown to cause CMT. We have generated mouse mutations in Lrsam1 to create an animal model of this form of CMT (CMT2P). Mouse Lrsam1 is abundantly expressed in the motor and sensory neurons of the peripheral nervous system. Both homozygous and heterozygous mice have largely normal neuromuscular performance and only a very mild neuropathy phenotype with age. However, Lrsam1 mutant mice are more sensitive to challenge with acrylamide, a neurotoxic agent that causes axon degeneration, indicating the axons in the mutant mice are indeed compromised. In transfected cells, LRSAM1 primarily localizes in a perinuclear compartment immediately beyond the Golgi and shows little colocalization with components of the endosome to lysosome trafficking pathway, suggesting that other cellular mechanisms also merit consideration.
- Received September 25, 2012.
- Accepted March 6, 2013.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Featured resource: A classification system for zebrafish adipose tissues
A new Resource article from James Minchin and John Rawls presents a standardized nomenclature and classification system for zebrafish adipose tissues, and regression models to predict expected adipose size during the course of zebrafish development.
Why should you publish your next paper in Disease Models & Mechanisms?
From single-celled organisms to patient-derived models, cancer to neurodegeneration, Disease Models & Mechanisms publishes the best original research and resources that focus on the use of model systems to better understand, diagnose and treat human disease. Submit your paper here.
Editor's choice: a powerful new model for neuropsychiatric disorders
A new Drosophila model to study the role of schizophrenia-associated gene PRODH in behavioural disorders has been developed by a team lead by Patrick Callaerts from the University of Leuven in Belgium. Their Research article describes how this model reveals that precise regulation of proline metabolism in the lateral neurons ventral region of the brain is crucial for maintaining normal behaviour patterns. Read a press release on the discovery here.
Focus on lysosomal storage diseases
In the latest issue, we present two new articles focused on lysosomal storage diseases (LSDs). A Research article from Michael Hoch and co-authors presents a detailed analysis of lipid accumulation, lysosomal dysfunction and neurodegeneration in a Drosophila sphingolipidosis model, while Ellen Sidransky et al. discuss how iPSCs provide new opportunities to explore the biology and pathophysiology of LSDs in a new Review.
Transfer to Biology Open
If your submission to Disease Models & Mechanisms is unsuccessful, did you know you can transfer your paper and any reviews directly to our sister journal, Biology Open? The majority of papers transferred with reviews are accepted for publication. Find out how here.